Catalyst Pharmaceutical
CPRX
CPRX
271 hedge funds and large institutions have $1.5B invested in Catalyst Pharmaceutical in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 91 increasing their positions, 90 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $1.53B → $1.5B (-$31.3M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
34% less call options, than puts
Call options by funds: $522K | Put options by funds: $789K
Holders
271
Holding in Top 10
4
Calls
$522K
Puts
$789K
Top Buyers
| 1 | +$45.9M | |
| 2 | +$34.8M | |
| 3 | +$14.9M | |
| 4 |
Renaissance Technologies
New York
|
+$4.45M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$4.26M |
Top Sellers
| 1 | -$32.8M | |
| 2 | -$12.2M | |
| 3 | -$8.53M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$7.19M |